Suchergebnisse - "Kiyoi, Hitoshi"

PubPharm (20)

1

Current progress and future perspectives of research on intravascular large B-cell lymphoma

enthalten in: Cancer science | 2021

von Shimada, K. | Kiyoi, H.

2

FLT3 mutations in acute myeloid leukemia : Therapeutic paradigm beyond inhibitor development

enthalten in: Cancer science | 2020

von Kiyoi, H. | Kawashima, N. | Ishikawa, Y.

3

Biology and management of primary effusion lymphoma

enthalten in: Blood | 2018

von Shimada, K. | Hayakawa, F. | Kiyoi, H.

4

Necessity of Genetic Examination in Treatment for Hematological Malignancies

enthalten in: Rinsho byori. The Japanese journal of clinical pathology | 2015

von Kiyoi, H.

5

FLT3 INHIBITORS : RECENT ADVANCES AND PROBLEMS FOR CLINICAL APPLICATION

enthalten in: Nagoya journal of medical science | 2015

von Kiyoi, H.

CommentIn: Nagoya J Med Sci. 2023 Feb;85(1):27-29. - PMID 36923638

6

Overview : A New Era of Cancer Genome in Myeloid Malignancies

enthalten in: Oncology | 2015

von Kiyoi, H.

7

Leukemia : recent progress in diagnosis and treatment. Topics: III. Diagnosis and treatments; 3. Treatment for acute promyelocytic leukemia

enthalten in: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine | 2013

von Kiyoi, H.

8

Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia

enthalten in: International journal of hematology | 2013

von Tomita, A. | Kiyoi, H. | Naoe, T.

9

Gene mutations of acute myeloid leukemia in the genome era

enthalten in: International journal of hematology | 2013

von Naoe, T. | Kiyoi, H.

10

Progress of pathophysiology and therapeutic evidence in AML

enthalten in: Rinsho ketsueki] The Japanese journal of clinical hematology | 2011

von Kiyoi, H.